PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.54%
Revenue growth above 1.5x M7U.DE's 5.57%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
18.42%
Positive gross profit growth while M7U.DE is negative. John Neff would see a clear operational edge over the competitor.
3.61%
EBIT growth below 50% of M7U.DE's 13.78%. Michael Burry would suspect deeper competitive or cost structure issues.
11.38%
Operating income growth at 75-90% of M7U.DE's 13.70%. Bill Ackman would demand a plan to enhance operating leverage.
15.82%
Net income growth above 1.5x M7U.DE's 8.77%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
16.67%
EPS growth above 1.5x M7U.DE's 6.06%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
16.67%
Diluted EPS growth above 1.5x M7U.DE's 6.06%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1640.45%
Dividend growth of 1640.45% while M7U.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-60.91%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-62.05%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
209.09%
10Y revenue/share CAGR above 1.5x M7U.DE's 111.85%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
88.60%
5Y revenue/share CAGR above 1.5x M7U.DE's 40.15%. David Dodd would look for consistent product or market expansions fueling outperformance.
86.60%
3Y revenue/share CAGR 1.25-1.5x M7U.DE's 58.91%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-22.10%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
83.73%
3Y OCF/share CAGR of 83.73% while M7U.DE is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
878.42%
Net income/share CAGR above 1.5x M7U.DE's 220.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
108.66%
5Y net income/share CAGR above 1.5x M7U.DE's 9.33%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
413.81%
3Y net income/share CAGR above 1.5x M7U.DE's 32.47%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
242.42%
10Y equity/share CAGR at 50-75% of M7U.DE's 341.31%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
142.47%
Below 50% of M7U.DE's 351.80%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
50.13%
3Y equity/share CAGR at 50-75% of M7U.DE's 92.62%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.99%
3Y dividend/share CAGR of 55.99% while M7U.DE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
40.31%
Our AR growth while M7U.DE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
27.84%
Inventory growth well above M7U.DE's 24.51%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
15.32%
Asset growth above 1.5x M7U.DE's 3.52%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.67%
BV/share growth above 1.5x M7U.DE's 5.12%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
15.98%
We have some new debt while M7U.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
29.03%
SG&A declining or stable vs. M7U.DE's 851.47%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.